National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease

References

• Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1–41. doi: 10.15585/mmwr.rr6909a1
   PubMed Web of Science ®Google Scholar
• Siddiqui JA, Ameer MA, Gulick PG. Meningococcemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. p. 1–7.
   Google Scholar
• Purmohamad A, Abasi E, Azimi T, et al. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: a systematic review and meta-analysis. Microb Pathog. 2019;134:103571. doi: 10.1016/j.micpath.2019.103571
   PubMed Web of Science ®Google Scholar
• Parikh S, Campbell H, Bettinger JA, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81(4):483–498. doi: 10.1016/j.jinf.2020.05.079
   PubMed Web of Science ®Google Scholar
• Acevedo R, Bai X, Borrow R, et al. The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations. Expert Rev Vaccines. 2019;18(1):15–30. doi: 10.1080/14760584.2019.1557520
   PubMed Web of Science ®Google Scholar
• Mbaeyi SA, Joseph SJ, Blain A, et al. Meningococcal disease among college-aged young adults: 2014–2016. Pediatrics. 2019;143:e20182130. doi: 10.1542/peds.2018-2130
   PubMed Web of Science ®Google Scholar
• Atkinson B, Gandhi A, Balmer P. History of meningococcal outbreaks in the United States: implications for vaccination and disease prevention. Pharmacotherapy. 2016;36(8):880–892. doi: 10.1002/phar.1790
   PubMed Web of Science ®Google Scholar
• Menactra (meningococcal [groups A, C, Y, and W-135] polysaccharide diphtheria toxoid conjugate vaccine solution for intramuscular injection). Full Prescribing Information. Swiftwater PA: 2019.
   Google Scholar
• Menveo (meningococcal [groups A, C, Y, and W-135] oligosaccharide diphtheria CRM₁₉₇ conjugate vaccine). Full Prescribing Information. Durham NC: GlaxoSmithKline; 2022.
   Google Scholar
• Nimenrix (meningococcal [groups A, C, W-135, and Y] conjugate vaccine). Summary of Product Characteristics. Bruxelles, Belgium: Pfizer Europe; 2017.
   Google Scholar
• MenQuadfi (meningococcal [groups A, C, Y, and W] conjugate vaccine). Full Prescribing Information. Swiftwater PA: Sanofi Pasteur Inc; 2022.
   Google Scholar
• Meningococcal A conjugate vaccine (MenAfriVac). Summary of Product Characteristics. Hadapsar Pune: Serum Institute of India Pvt Ltd; 2023.
   Google Scholar
• Menjugate liquid (10 microgram suspension for injection; meningococcal group C conjugate vaccine). Siena, Italy: Summary of Product Characteristics. GlaxoSmithKline Inc; 2021.
   Google Scholar
• Package leaflet: NeisVac-C vaccine. Summary of Product Characteristics. Dublin Ireland: Pfizer Healthcare Ireland; 2022.
   Google Scholar
• Menitorix powder and solvent for solution for injection. Summary of Product Characteristics. Brentford, Middlesex: GlaxoSmithKline UK; 2020.
   Google Scholar
• Trumenba (meningococcal group B vaccine suspension for intramuscular injection). Full Prescribing Information. Philadelphia PA: Pfizer Inc; 2021.
   Google Scholar
• Bexsero (Meningococcal group B vaccine suspension for intramuscular injection). Full Prescribing Information. Research Triangle Park, NC: GlaxoSmithKline; 2022.
   Google Scholar
• MacNeil JR, Blain AE, Wang X, et al. Current epidemiology and trends in meningococcal disease-United States, 1996–2015. Clin Infect Dis. 2018;66:1276–1281. doi: 10.1093/cid/cix993
   PubMed Web of Science ®Google Scholar
• Guedes S, Bricout H, Langevin E, et al. Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis. BMC Public Health. 2022;22:521. doi: 10.1186/s12889-022-12933-3
   PubMed Web of Science ®Google Scholar
• Archer BN, Chiu CK, Jayasinghe SH, et al. Epidemiology of invasive meningococcal B disease in Australia, 1999–2015: priority populations for vaccination. Med J Aust. 2017;207:382–387. doi: 10.5694/mja16.01340
   PubMed Web of Science ®Google Scholar
• Mandal S, Campbell H, Ribeiro S, et al. Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine. Vaccine. 2017;35(43):5814–5818. doi: 10.1016/j.vaccine.2017.09.024
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . Enhanced meningococcal disease surveillance report, 2018 [Internet]. [ cited 2023 Sep 7]; https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2018.pdf
   Google Scholar
• Bassi C, Taha MK, Merle C, et al. A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017. Euro Surveill. 2017;22(28). doi: 10.2807/1560-7917.ES.2017.22.28.30574
   PubMedGoogle Scholar
• Barret AS, Clinard F, Taha MK, et al. Cluster of serogroup W invasive meningococcal disease in a university campus. Med Mal Infect. 2020;50(4):335–341. doi: 10.1016/j.medmal.2019.10.003
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60:65–68.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Taking complement inhibitors increases your risk for meningococcal disease [Internet]. [cited 2023 Sep 7]; https://www.cdc.gov/meningococcal/about/soliris-patients.html
   Google Scholar
• Folaranmi TA, Kretz CB, Kamiya H, et al. Increased risk for meningococcal disease among men who have sex with men in the United States, 2012–2015. Clin Infect Dis. 2017;65:756–763. doi: 10.1093/cid/cix438
   PubMed Web of Science ®Google Scholar
• Bozio CH, Blain A, MacNeil J, et al. Meningococcal disease surveillance in men who have sex with men - United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 2018;67:1060–1063. doi: 10.15585/mmwr.mm6738a4
   PubMed Web of Science ®Google Scholar
• Serra LC, York LJ, Gamil A, et al. A review of meningococcal disease and vaccination recommendations for travelers. Infect Dis Ther. 2018;7(2):219–234. doi: 10.1007/s40121-018-0196-z
   PubMed Web of Science ®Google Scholar
• Taha MK, Weil-Olivier C, Bouée S, et al. Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database. Hum Vaccin Immunother. 2021;17(6):1858–1866. doi: 10.1080/21645515.2020.1849518
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2021 [Internet]. [cited 2023 Sep 7]; Available from 2023: https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2021.pdf
   Google Scholar
• Burman C, Serra L, Nuttens C, et al. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019;15(2):459–469. doi: 10.1080/21645515.2018.1528831
   PubMed Web of Science ®Google Scholar
• Millar BC, Moore PJA, Moore JE. Meningococcal disease: has the battle been won? J R Army Med Corps. 2017;163(4):235–241. doi: 10.1136/jramc-2016-000695
   PubMed Web of Science ®Google Scholar
• McNamara LA, Topaz N, Wang X, et al. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep. 2017;66(27):734–737. doi: 10.15585/mmwr.mm6627e1
   PubMed Web of Science ®Google Scholar
• Ohm M, van Straalen JW, Zijlstra M, et al. Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: a prospective observational cohort study. Vaccine. 2023;41(25):3782–3789. doi: 10.1016/j.vaccine.2023.04.056
   PubMed Web of Science ®Google Scholar
• Balmer P, Falconer M, McDonald P, et al. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun. 2004;72(1):332–337. doi: 10.1128/IAI.72.1.332-337.2004
   PubMed Web of Science ®Google Scholar
• Siberry GK, Williams PL, Lujan-Zilbermann J, et al. Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents. Pediatr Infect Dis J. 2010;29(5):391–396. doi: 10.1097/INF.0b013e3181c38f3b
   PubMed Web of Science ®Google Scholar
• Bertolini DV, Costa LS, van der Heijden IM, et al. Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults. Vaccine. 2012;30(37):5482–5486. doi: 10.1016/j.vaccine.2012.06.069
   PubMed Web of Science ®Google Scholar
• Frota AC, Milagres LG, Harrison LH, et al. Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil. Pediatr Infect Dis J. 2015;34:e113–118. doi: 10.1097/INF.0000000000000630
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health and Aged Care. Meningococcal vaccination for people in a special risk group [Internet]. [cited 2023 Sep 7]; https://immunisationhandbook.health.gov.au/sites/default/files/2023-03/AIH-Meningococcal-Other-07%2822Mar23%29.pdf
   Google Scholar
• Australian Government Department of Health. The Australian immunisation program schedule (Current from 6 February 2023) [Internet]. [cited 7 Sep 2023]; https://www.health.gov.au/sites/default/files/2023-07/national-immunisation-program-schedule.pdf
   Google Scholar
• Ministry of Health of Brazil. Manual dos centros de referência para immunobiológicos especiais [Internet]. [cited 2023 Sep 7]; http://bvsms.saude.gov.br/bvs/publicacoes/manual_centros_imunobiologicos_especiais_5ed.pdf
   Google Scholar
• Ministère de la Santé et de la Prévention. Calendrier des vaccinations et recommandations vaccinales [Internet]. [cited 2023 Sep 7]; https://sante.gouv.fr/prevention-en-sante/preserver-sa-sante/vaccination/calendrier-vaccinal
   Google Scholar
• Santé Publique France. Recommandations sanitaires pour les voyageurs, 2019 [Internet]. [cited 2023 Sep 7]; https://www.santepubliquefrance.fr/docs/recommandations-sanitaires-pour-les-voyageurs-2019-a-l-attention-des-professionnels-de-sante
   Google Scholar
• STIKO. Recommendations of the standing committee on vaccination (STIKO) at the Robert Koch Institute. Epidemilogisches Bulletin. 2017;34:333–376.
   Google Scholar
• North Atlantic Treaty Organization. Standards related document. AJMedP-4-7. Vaccinations catalogue within the NATO & PfP forces [Internet]. [cited 2023 Sep 7]; https://www.coemed.org/files/stanags/02_AJMEDP/AJMedP-4-7_SRD_EDA_V1_E_2561.pdf
   Google Scholar
• Ireland National Immunisation Advisory Committee. Chapter 13. Meningococcal infection [Internet]. [ cited 2023 Sep 7]; Available from: https://rcpi.access.preservica.com/uncategorized/IO_cf46ea72-2756-4e96-b22c-8e088ab7b9e4/
   Google Scholar
• Ireland National Immunisation Advisory Committee. Chapter 3. Immunisation of immunocompromised persons [Internet]. [cited 7 Sep 2023]; https://rcpi.access.preservica.com/uncategorized/IO_58401d43-5ce9-4aa0-858f-e5236cad3e27/
   Google Scholar
• Ireland National Immunisation Advisory Committee. Chapter 5. Immunisations and health information for travel [Internet] [cited 2023 Sep 7]; https://rcpi.access.preservica.com/uncategorized/IO_6f3f6a98-9086-458c-aedc-84e218487e15/
   Google Scholar
• State of Israel Ministry of Health Department of Epidemiology. National vaccination guidelines: prevention and control of meningococcal diseases [internet]. [cited 2023 Sep 7]; https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/td/docs/320_MM.pdf
   Google Scholar
• Ministry of Health of Italy. National vaccination plan 2017–2019 [Internet]. [cited 2023 Sep 7]; http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
   Google Scholar
• Bonanni P, Grazzini M, Niccolai G, et al. Recommended vaccinations for asplenic and hyposplenic adult patients. Hum Vaccin Immunother. 2017;13(2):359–368. doi: 10.1080/21645515.2017.1264797
   PubMed Web of Science ®Google Scholar
• National Institute for Public Health and the Environment. Meningococcal disease in the Netherlands, RIVM Report 2017-0031 [Internet]. [cited 2023 Sep 7]; https://www.rivm.nl/bibliotheek/rapporten/2017-0031.pdf
   Google Scholar
• New Zealand Ministry of Health. Immunisation handbook (2nd edition) [Internet]. [cited 2023 Sep 7]; Available from: https://www.health.govt.nz/our-work/immunisation-handbook-2020
   Google Scholar
• New Zealand Immunisation Advisory Centre. Meningococcal disease [Internet]. [cited 2023 Sep 7]; https://www.immune.org.nz/diseases/meningococcal-disease
   Google Scholar
• Portugal Ministry of Health. Programa nacional de vacinação [Internet] [cited 2023 Sep7]; https://www.sns.gov.pt/noticias/2020/09/30/programa-nacional-de-vacinacao-2020/
   Google Scholar
• García FJ Á, Cilleruelo Ortega MJ, Álvarez Aldeán J, et al. Immunization schedule of the Pediatric Spanish Association: 2022 recommendations. An Pediatr (Engl Ed). 2022;96:.e59.51–.e59.10. doi: 10.1016/j.anpede.2021.11.002
   Web of Science ®Google Scholar
• General Directorate of Public Health Turkey. Hajj and Umrah vaccines [Internet]. [cited 2023 Sep 7]; https://asi.saglik.gov.tr/asi-kimlere-yapilir/liste/31-hac-ve-umre-a%C5%9F%C4%B1lamalar%C4%B1.html
   Google Scholar
• Ceyhan M, Ozsurekci Y, Tanır Basaranoglu S, et al. Multicenter hospital-based prospective surveillance study of bacterial agents causing meningitis and seroprevalence of different serogroups of Neisseria meningitidis, Haemophilus influenzae type b, and Streptococcus pneumoniaeduring 2015 to 2018 in Turkey. mSphere. 2020;5(2). doi: 10.1128/mSphere.00060-20
   PubMed Web of Science ®Google Scholar
• General Directorate of Public Health Turkey. Required vaccines and application schemes for healthcare professionals [Internet]. [cited 2023 Apr 13]. Available from: https://hsgm.saglik.gov.tr/tr/saglik-calisanlari-asilama.html
   Google Scholar
• Medicana Health Group. Meningococcal vaccine [Internet]. [cited 2023 Apr 13]. Available from: https://www.medicana.com.tr/saglik-rehberi-detay/12474/meningokok-asisi
   Google Scholar
• National Health Service. MenACWY vaccine overview [Internet]. [cited 2023 Sep 7]; https://www.nhs.uk/conditions/vaccinations/men-acwy-vaccine/
   Google Scholar
• Public Health England. Chapter 12. Immunisation of Healthcare and Laboratory Staff. In: The Green Book. (UK); 2013.
   Google Scholar
• National Health Service. The routine immunisation schedule [Internet]. [cited 2023 Sep 7]; https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1055877/UKHSA-12155-routine-complete-immunisation-schedule_Feb2022.pdf
   Google Scholar
• National Health Service. Available vaccines: travel vaccinations [Internet]. [cited 2023 Sep 7]; https://www.nhs.uk/conditions/travel-vaccinations/jabs/
   Google Scholar
• United Kingdom Royal Navy. Vaccinations [Internet]. [cited 2023 Sep 7]; https://www.royalnavy.mod.uk/careers/joining/get-fit-to-join/advice-and-guidance/food-drink-and-lifestyle/lifestyle/vaccinations
   Google Scholar
• The British Army. Vaccination in the armed forces – what you need to know [Internet]. [cited 2023 Sep 7]; https://www.army.mod.uk/umbraco/Surface/Download/Get/4122
   Google Scholar
• Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older [Internet]. [cited 2023 Sep 7]; https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf
   Google Scholar
• Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger: United States 2023 [Internet]. [cited 2023 Sep 7]; https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf
   Google Scholar
• Patton ME, Stephens D, Moore K, et al. Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine - Advisory Committee on Immunization Practices, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:509–513. doi: 10.15585/mmwr.mm6619a6
   PubMed Web of Science ®Google Scholar
• Arvas A. Vaccination in patients with immunosuppression. Turk Pediatri Ars. 2014;49:181–185. doi: 10.5152/tpa.2014.2206
   PubMedGoogle Scholar
• Arisoy E, Çiftçi E, Hacimustafaoglu M, et al. Clinical practical recommendations for Turkish national vaccination schedule for previously healthy children (national vaccination schedule) and vaccines not included in the schedule - 2015. J Pediatr Inf. 2015;9:1–11. doi: 10.5152/ced.2015.1516
   Web of Science ®Google Scholar
• Di Giuseppe G, Pelullo CP, Della Polla G, et al. Meningococcal disease and related vaccinations: knowledge, attitudes, and practices among healthcare workers who provide care to patients with underlying high-risk medical conditions. Vaccines (Basel). 2020;8(3):543. doi: 10.3390/vaccines8030543
   PubMed Web of Science ®Google Scholar
• van Veen KE, Brouwer MC, van der Ende A, et al. Bacterial meningitis in diabetes patients: a population-based prospective study. Sci Rep. 2016;6(1):36996. doi: 10.1038/srep36996
   PubMedGoogle Scholar
• Hanley JF, Bales JD Jr., Byrd B. Recurrent meningococcal meningitis with occult CSF leak. Arch Intern Med. 1979;139:702–703. doi: 10.1001/archinte.1979.03630430078026
   PubMedGoogle Scholar
• Societa Italiana di Pediatria. Calendario vaccinale per la vita [Internet]. [cited 2023 Sep 7]; http://www.igienistionline.it/docs/2019/21cvplv.pdf
   Google Scholar
• Republica Italiana. Piano nazionale prevenzione vaccinale PNPV 2017–2019 [Internet]. [cited 2023 Sep 7]; https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
   Google Scholar
• New Zealand Immunisation Advisory Centre. Bexsero funded from 1 March 2023 [Internet]. [cited 2023 Sep 7]. Available from. https://www.immune.org.nz/news/bexsero-funded-from-1-march-2023
   Google Scholar
• Moreno-Perez D, Garcia Alvarez FJ, Aldean JA, et al. Calendario de vacunaciones de la Asociación Espanola de Pediatría (CAV-AEP): recomendaciones 2018. An Pediatr (Barc). 2018;88:e53.51–e53.59. doi: 10.1016/j.anpedi.2017.10.001
   Google Scholar
• World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary [Internet]. [cited 2022 Sep 7]. Available from: https://immunizationdata.who.int/pages/indicators-by-category/planning_and_management.html?ISO_3_CODE=&YEAR=
   Google Scholar
• Ireland Health Service Executive. Going to Irish college? Are your vaccines up to date? [Internet]. [cited 2023 Sep 7]; https://www.hse.ie/eng/health/immunisation/news/irishcollege%20.html
   Google Scholar
• Fawole OA, Srivastava T, Fasano C, et al. Evaluating variability in immunization requirements and policy among U.S. colleges and universities. J Adolesc Health. 2018;63(3):286–292. doi: 10.1016/j.jadohealth.2018.06.013
   PubMed Web of Science ®Google Scholar
• Wilson N, Baker M, Martin D, et al. Meningococcal disease epidemiology and control in New Zealand. N Z Med J. 1995;108:437–442.
   PubMed Web of Science ®Google Scholar
• Dinleyici EC, Borrow R. Meningococcal infections among refugees and immigrants: silent threats of past, present and future. Hum Vaccin Immunother. 2020;16(11):2781–2786. doi: 10.1080/21645515.2020.1744979
   PubMed Web of Science ®Google Scholar
• Massey P, Durrheim D. Aboriginal and Torres Strait Islander peoples at higher risk of invasive meningococcal disease in NSW. N S W Public Health Bull. 2008;19(6):100–103. doi: 10.1071/NB07047
   PubMedGoogle Scholar
• Centre for Public Impact. New Zealand’s meningococcal B immunisation programme [Internet]. [cited 2023 Sep 7]; https://www.centreforpublicimpact.org/case-study/meningococcal-b-immunisation-programme/
   Google Scholar
• Centers for Disease Control and Prevention. Meningococcal disease [Internet]. [cited 2023 Sep 7]; https://www.cdc.gov/meningococcal/downloads/17-275138A-MeningococcalDis-FS.pdf
   Google Scholar
• Broderick MP, Faix DJ, Hansen CJ, et al. Trends in meningococcal disease in the United States military, 1971–2010. Emerg Infect Dis. 2012;18:1430–1437. doi: 10.3201/eid1809.120257
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health & Human Services. Vaccines for military members [Internet]. [cited 2023 Sep 7]; https://www.vaccines.gov/who_and_when/military_members
   Google Scholar
• Broderick MP, Phillips C, Faix D. Meningococcal disease in US military personnel before and after adoption of conjugate vaccine. Emerg Infect Dis. 2015;21(2):377–379. doi: 10.3201/eid2102.141037
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Rapid risk assessment: invasive meningococcal disease among men who have sex with men [Internet]. [cited 2023 Sep 7]; https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/rapid-risk-assessment-invasive-meningococcal-disease-among-MSM.pdf
   Google Scholar
• New York City Department of Health and Hygiene. UPDATE: Invasive meningococcal disease in men who have sex with men, four new cases reported in 2013, expanded vaccine recommendations [Internet]. [cited 2023 Sep 7]. Available from: https://cdn.hivguidelines.org/wp-content/uploads/20160817171429/alert-5-invasive-meningococcal-disease-in-msm-03-06-2013.pdf
   Google Scholar
• State of Israel Ministry of Health. The Ministry of Health advises men who have sex with men who are planning to fly to New York to be vaccinated against meningitis (meningococcus) [Internet]. [cited 2023 Sep 7]; https://www.health.gov.il/English/News_and_Events/Spokespersons_Messages/Pages/28042013_1.aspx
   Google Scholar
• US Centers for Disease Control and Prevention. Meningococcal disease outbreak among gay, bisexual men in Florida, 2021–2023 [Internet]. [cited 2023 Sep 07]; https://www.cdc.gov/meningococcal/outbreaks/FL2022.html
   Google Scholar
• Lucidarme J, Hill DM, Bratcher HB, et al. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect. 2015;71:544–552. doi: 10.1016/j.jinf.2015.07.007
   PubMed Web of Science ®Google Scholar
• Smith-Palmer A, Oates K, Webster D, et al. Outbreak of Neisseria meningitidis capsular group W among scouts returning from the World Scout Jamboree, Japan, 2015. Euro Surveill. 2016;21(45). doi: 10.2807/1560-7917.ES.2016.21.45.30392
   Google Scholar
• Aguilera JF, Perrocheau A, Meffre C, et al. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis. 2002;8:761–767. doi: 10.3201/eid0808.010422
   PubMed Web of Science ®Google Scholar
• Peterson ME, Mile R, Li Y, et al. Meningococcal carriage in high-risk settings: a systematic review. Int J Infect Dis. 2018;73:109–117. doi: 10.1016/j.ijid.2018.05.022
   PubMed Web of Science ®Google Scholar
• Badahdah AM, Alfelali M, Alqahtani AS, et al. Mandatory meningococcal vaccine, and other recommended immunisations: uptake, barriers, and facilitators among health care workers and trainees at Hajj. World J Clin Cases. 2018;6(16):1128–1135. doi: 10.12998/wjcc.v6.i16.1128
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Saudi Arabia: Hajj & Umrah Pilgrimages. [cited 2023 Sep 7]; https://wwwnc.cdc.gov/travel/yellowbook/2024/itineraries/saudi-arabia-hajj-and-umrah-pilgrimages
   Google Scholar
• Bengtson L, Marshall GS, Buikema AR, et al. Meningococcal vaccination among patients newly diagnosed at high-risk for meningococcal disease in the United States. Open Forum Infect Dis. 2019;6:S959–S960. doi: 10.1093/ofid/ofz360.2403
   Google Scholar
• Ghaswalla PK, Bengtson LGS, Marshall GS, et al. Meningococcal vaccination in patients with newly diagnosed asplenia in the United States. Vaccine. 2021;39(2):272–281. doi: 10.1016/j.vaccine.2020.11.068
   PubMed Web of Science ®Google Scholar
• Ghaswalla PK, Marshall GS, Bengtson LGS, et al. Meningococcal vaccination rates among people with a new diagnosis of HIV infection. JAMA Netw Open. 2022;5(4):e228573. doi: 10.1001/jamanetworkopen.2022.8573
   PubMed Web of Science ®Google Scholar
• Marshall GS, Ghaswalla PK, Bengtson LGS, et al. Low meningococcal vaccination rates among patients with newly diagnosed complement component deficiencies. Clin Infect Dis. 2022;75(1):155–158. doi: 10.1093/cid/ciab917
   PubMed Web of Science ®Google Scholar
• Blagden S, Seddon D, Hungerford D, et al. Uptake of a new meningitis vaccination programme amongst first-year undergraduate students in the United Kingdom: a cross-sectional study. PLoS One. 2017;12(8):e0181817. doi: 10.1371/journal.pone.0181817
   PubMed Web of Science ®Google Scholar
• Wang B, Giles L, Andraweera P, et al. Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study. Lancet Infect Dis. 2022;22(7):1011–1020. doi: 10.1016/S1473-3099(21)00754-4
   PubMed Web of Science ®Google Scholar
• AlQuliti KW, Tajaddin WA, Habeeb HA, et al. Meningococcal immunization among emergency room health careworkers in Almadinah Almunawwarah, Saudi Arabia. J Taibah University Med Sci. 2015;10:175–180. doi: 10.1016/j.jtumed.2015.01.013
   Google Scholar
• Madani TA, Ghabrah TM. Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj. BMC Infect Dis. 2007;7(1):80. doi: 10.1186/1471-2334-7-80
   PubMedGoogle Scholar
• Ferrara P, Stromillo L, Albano L. Awareness, attitudes, and practices toward meningococcal B vaccine among pediatricians in Italy. Med (Kaunas). 2018;54(6):100. doi: 10.3390/medicina54060100
   PubMed Web of Science ®Google Scholar
• Le Marechal M, Agrinier N, Fressard L, et al. Low uptake of meningococcal C vaccination in France: a cross-sectional nationwide survey of general practitioners’ perceptions, attitudes and practices. Pediatr Infect Dis J. 2017;36(7):e181–e188. doi: 10.1097/INF.0000000000001553
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global market study: meningococcal meningitis vaccines [Internet]. [cited 2023 Sep 7]; https://cdn.who.int/media/docs/default-source/immunization/mi4a/who_meningococcal_vaccines_public_summary.pdf?sfvrsn=b3fb96f7_6&download=true
   Google Scholar
• Sulis G, Horn M, Borrow R, et al. A comparison of national vaccination policies to prevent serogroup B meningococcal disease. Vaccine. 2022;40(26):3647–3654. doi: 10.1016/j.vaccine.2022.04.101
   PubMed Web of Science ®Google Scholar
• Brazilian Society of Immunization. Meningococcal B vaccines [Internet]. [cited 2023 Sep 7]. Available from: https://familia.sbim.org.br/vacinas/vacinas-disponiveis/vacina-meningococica-b
   Google Scholar
• Northern Territory Government. Immunisation schedule for children up to 19 years [Internet] [cited 2023 Sep 7]; https://digitallibrary.health.nt.gov.au/prodjspui/handle/10137/776
   Google Scholar
• Gounder PP, Zulz T, Desai S, et al. Epidemiology of bacterial meningitis in the North American Arctic, 2000–2010. J Infect. 2015;71:179–187. doi: 10.1016/j.jinf.2015.04.001
   PubMed Web of Science ®Google Scholar
• Government of Canada. Recommended immunization schedules: Canadian immunization guide [Internet]. [cited 2023 Sep 7]; https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-1-key-immunization-information/page-13-recommended-immunization-schedules.html
   Google Scholar
• Borrow R, Findlow J, Gray S, et al. Safe laboratory handling of Neisseria meningitidis. J Infect. 2014;68(4):305–312. doi: 10.1016/j.jinf.2014.01.003
   PubMed Web of Science ®Google Scholar
• Huang L, Goren A, Lee LK, et al. Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations. Hum Vaccin Immunother. 2020;16(4):933–944. doi: 10.1080/21645515.2019.1682845
   PubMed Web of Science ®Google Scholar
• Saez-Llorens X, Beltran-Rodriguez J, Novoa Pizarro JM, et al. Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults. Hum Vaccin Immunother. 2018;14(5):1161–1174. doi: 10.1080/21645515.2018.1457595
   PubMed Web of Science ®Google Scholar
• Alderfer J, Isturiz RE, Srivastava A. Lessons from mass vaccination response to meningococcal B outbreaks at US universities. Postgrad Med. 2020;132(7):614–623. doi: 10.1080/00325481.2020.1766265
   PubMed Web of Science ®Google Scholar
• World Health Organization. Defeating meningitis by 2030: a global road map [Internet]. [cited 2023 Sep 7]; https://www.who.int/publications/i/item/9789240026407
   Google Scholar
• Pan American Health Organization, World Health Organization. Meningococcus [Internet]. [cited 2023 Sep 7]; https://www.paho.org/en/topics/meningococcus
   Google Scholar